NovelStem Provides Shareholder Update
The original release is unavailable here.
Earlier from Novelstem International
- Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies
- NewStem Announces $4 million Seed Investment
- Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance
- Hollywood Media Advances Pay Date to March 29 for $0.45 per Share Special Distribution